The trial was testing the pill, SU-11248, as a treatment for gastrointestinal stromal tumors (GIST).

FORBES: Pfizer Cancer Pill Proves Effective

One piece of evidence is in the trials Demetri conducted of Sutent for gastrointestinal stromal tumors (GIST), a deadly disease but a tiny market.

FORBES

Sutent is being submitted for both gastrointestinal stromal tumors that have failed to respond to Gleevec, a drug from Novartis and for kidney cancer that has not responded to other treatments.

FORBES: Magazine Article

In November, NICE denied payment for a higher-than-standard dose of Glivec (Gleevec in the U.S.) for gastrointestinal stromal tumors, although some patients (14%, according to the manufacturer of the drug) would benefit from the higher dosage.

FORBES: Comparative Effectiveness: Hope Or Hype?

Sutent is being submitted for both gastrointestinal stromal tumors that have failed to respond to Gleevec, a drug from Novartis (nyse: NVS - news - people ) and for kidney cancer that has not responded to other treatments.

FORBES: McKinnell's Pfizer Submits 'Revolutionary' Cancer Drug